The Fed is expected to cut rates multiple times, but the reason behind those cuts could have vastly different implications for the market.Marketsread more
"This is going to be the biggest thing that's happened to Facebook in years," says CNBC's Jim Cramer. "It will be vital."Investingread more
These are the stocks posting the largest moves midday.Market Insiderread more
The red-hot market for new public companies in 2019 like Beyond Meat and Chewy could spell bad news for the stock market, Bernstein says.Marketsread more
The "captive carry flight test" evaluates the mock weapon during flight and is the Air Force's latest step in the budding hypersonic arms race between China and Russia.Politicsread more
It's about time to write off high-growth tech stocks, Goldman warns, saying software carries the highest multiples since the tech bubble.Marketsread more
Profits for major U.S. tobacco companies could be cut in half if the FDA adopts a "maximum nicotine" rule within the next 15 years, according to analysts at Morgan Stanley.Tobaccoread more
Former Egyptian president Mohamed Mursi has died in court, state television reported on Monday.World Politicsread more
Iran will surpass the internationally agreed levels of its low-enriched uranium levels in 10 days, the country's atomic energy body said Monday.Politicsread more
Boeing says the airline industry will need 44,000 new commercial airplanes by 2038. The market value of those planes would reach $6.8 trillion, up from $6.49 trillion...Airlinesread more
Apple is reportedly building three new iPhones for 2020, including two with 5G. It may also slightly change the screen sizes of the new iPhones.Technologyread more
There's a new shuttle service in California, and it's on a mission to help seniors with their aches and pains. But riders won't find any Tylenol or Advil on this particular trip to the drug store.
Instead, this bus serves as a cannabis run.
The shuttle is provided by the marijuana dispensary Bud and Bloom. Once a month, it takes retirees from Laguna Woods Village, a senior living community in southern California on a half hour drive to its dispensary in Santa Ana.
Before going in, a representative from Bud and Bloom, as well as other marijuana vendors, will take turns talking to the group about the potential benefits of cannabis, and how it can be consumed.
"I think it's very important to engage the senior community. It's a growing segment of society especially as people get older because of the excellent health care in our society," Bud and Bloom owner Scott Miller told CNBC.
And the popularity of marijuana among boomers and seniors is growing rapidly. According to recent research from Cowen and Company and the 2017 National Survey on Drug Use and Health, cannabis users age 55 and up nearly quadrupled in the last ten years. That segment skyrocketed from 5 percent to 18 percent, as older Americans flocked to medical marijuana.
Meanwhile, over 30 states and the District of Columbia have legalized pot for medical or recreational use.
Shari Horn, a former resident of the Laguna Woods Village who is now an advocate of medical marijuana and a member of the city council, uses topicals and tinctures derived from pot in order to ease arthritis pain.
"I've been using cannabis my whole life, you know, way back in the 60s," Horn tells CNBC.
But for others who are less familiar with marijuana, the shuttle serves as an educational tool.
"The idea here really is to educate. These field trips are not just an opportunity to market to the senior community, but an opportunity to educate. And then they tell their friends, and it grows, it gets attention," said Miller.
Still, not everyone is in favor of the idea. Sandy Sopher, a senior who uses cannabis for pain, told CNBC that social stigma is still a barrier to wider adoption.
"I had a neighbor and she doesn't even want to talk to me anymore because she found out I smoke cannabis," said Sopher.
Earlier this month, Canada legalized marijuana for recreational use, and analysts are closely watching the reaction to see how that could impact the United States.
Cowen Senior analyst Vivien Azer told CNBC that Canada's experience could provide insight into how pot gets adopted by a society at large, and whether that erodes the stigma of its use.
As many people claim the medical benefits of the drug, there has been little scientific research done because of its legal status.
"The DEA has started to give approvals to Canadian companies to actually import their cannabis to academic institutions in United States for research," Azer told CNBC.
While she doesn't expect federal legalization anytime soon in the U.S., "we expect things to continue on a state by state basis in the near term."
She added: "The midterms will be critical in terms of watching for that evolution."
On the Money airs on CNBC Saturdays at 5:30 am ET, or check listings for air times in local markets.